Form 4 holding
Chief Development Officer
Protagonist Therapeutics, Inc
- Security class
- Common Stock
- Shares / value
- 267,433
- Estimated value
- $3,254,660
- Report date
- 26 Nov 2024
- Price
- $12.17
- Ownership
- Direct
Suneel Gupta - Chief Development Officer at Protagonist Therapeutics, Inc
Issuer-level insider activity
- Role
- Chief Development Officer
- Issuer ticker
- PTGX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Suneel Gupta since 13 Sep 2025
Reported holdings for Suneel Gupta in Protagonist Therapeutics, Inc
Form 4 holding
Chief Development Officer
Protagonist Therapeutics, Inc
- Security class
- Stock Option (right to buy)
- Shares / value
- 93,300
- Estimated value
- Report date
- 26 Nov 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Suneel Gupta in Protagonist Therapeutics, Inc
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.